Sign in to view content

Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)

Dante Joseph Pieramici, MD

Video
Published 2020

Related

Vision Threatening Complications in Patients With Diabetic Macular Edema: A Post Hoc Analysis of the VISTA and VIVID Trials
Diana V Do, MD, FASRS
Annual Meeting Talks
2019
Part 1: Screening Diabetic Patients and Capturing Those with Retinopathy through Collaboration with PCPs using PCP-stationed Fundus Cameras and Telemedicine
Jose Agustin Martinez, MD
On Demand Cases, Courses, and Papers
2017
Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Thomas A. Ciulla, MD, MBA, FASRS
Updates from the Field
2017

Category: Diabetic Retinopathy

See more